Milestone Scientific (NYSE:MLSS) Now Covered by Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Milestone Scientific (NYSE:MLSS) in a research note issued on Monday. The brokerage set a “hold” rating on the stock.

Separately, Benchmark restated a “speculative buy” rating and set a $1.25 target price on shares of Milestone Scientific in a report on Wednesday, November 20th.

Milestone Scientific Stock Performance

Shares of MLSS opened at $1.18 on Monday. Milestone Scientific has a twelve month low of $0.54 and a twelve month high of $1.27. The firm’s 50 day moving average price is $0.86 and its two-hundred day moving average price is $0.89. The firm has a market cap of $91.91 million, a P/E ratio of -16.85 and a beta of 1.10.

Insider Transactions at Milestone Scientific

In other news, Director Leonard Osser sold 107,984 shares of Milestone Scientific stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $0.93, for a total value of $100,425.12. Following the completion of the sale, the director now owns 4,606,882 shares in the company, valued at $4,284,400.26. The trade was a 2.29 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Corporate insiders own 24.75% of the company’s stock.

Hedge Funds Weigh In On Milestone Scientific

A number of hedge funds have recently bought and sold shares of the company. World Investment Advisors LLC purchased a new position in shares of Milestone Scientific in the 3rd quarter worth about $91,000. Y Intercept Hong Kong Ltd purchased a new position in shares of Milestone Scientific in the 3rd quarter worth about $48,000. Finally, Geode Capital Management LLC boosted its holdings in shares of Milestone Scientific by 6.4% in the 3rd quarter. Geode Capital Management LLC now owns 527,005 shares of the company’s stock worth $480,000 after buying an additional 31,572 shares during the last quarter. 5.79% of the stock is owned by hedge funds and other institutional investors.

Milestone Scientific Company Profile

Milestone Scientific Inc, a biomedical technology research and development company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical, dental, and cosmetic use in the United States, China, and internationally. The company operates through Dental and Medical segments.